Recent dynamics in Neisseria gonorrhoeae genomic epidemiology in Brazil: antimicrobial resistance and genomic lineages in 2017-20 compared to 2015-16

J Antimicrob Chemother. 2024 May 2;79(5):1081-1092. doi: 10.1093/jac/dkae075.

Abstract

Objectives: Regular quality-assured WGS with antimicrobial resistance (AMR) and epidemiological data of patients is imperative to elucidate the shifting gonorrhoea epidemiology, nationally and internationally. We describe the dynamics of the gonococcal population in 11 cities in Brazil between 2017 and 2020 and elucidate emerging and disappearing gonococcal lineages associated with AMR, compare to Brazilian WGS and AMR data from 2015 to 2016, and explain recent changes in gonococcal AMR and gonorrhoea epidemiology.

Methods: WGS was performed using Illumina NextSeq 550 and genomes of 623 gonococcal isolates were used for downstream analysis. Molecular typing and AMR determinants were obtained and links between genomic lineages and AMR (determined by agar dilution/Etest) examined.

Results: Azithromycin resistance (15.6%, 97/623) had substantially increased and was mainly explained by clonal expansions of strains with 23S rRNA C2611T (mostly NG-STAR CC124) and mtr mosaics (mostly NG-STAR CC63, MLST ST9363). Resistance to ceftriaxone and cefixime remained at the same levels as in 2015-16, i.e. at 0% and 0.2% (1/623), respectively. Regarding novel gonorrhoea treatments, no known zoliflodacin-resistance gyrB mutations or gepotidacin-resistance gyrA mutations were found. Genomic lineages and sublineages showed a phylogenomic shift from sublineage A5 to sublineages A1-A4, while isolates within lineage B remained diverse in Brazil.

Conclusions: Azithromycin resistance, mainly caused by 23S rRNA C2611T and mtrD mosaics/semi-mosaics, had substantially increased in Brazil. This mostly low-level azithromycin resistance may threaten the recommended ceftriaxone-azithromycin therapy, but the lack of ceftriaxone resistance is encouraging. Enhanced gonococcal AMR surveillance, including WGS, is imperative in Brazil and other Latin American and Caribbean countries.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Anti-Bacterial Agents* / pharmacology
  • Azithromycin* / pharmacology
  • Brazil / epidemiology
  • Cefixime / pharmacology
  • Ceftriaxone / pharmacology
  • Drug Resistance, Bacterial* / genetics
  • Female
  • Genome, Bacterial
  • Genomics
  • Gonorrhea* / epidemiology
  • Gonorrhea* / microbiology
  • Humans
  • Male
  • Microbial Sensitivity Tests*
  • Middle Aged
  • Molecular Epidemiology
  • Multilocus Sequence Typing
  • Neisseria gonorrhoeae* / classification
  • Neisseria gonorrhoeae* / drug effects
  • Neisseria gonorrhoeae* / genetics
  • RNA, Ribosomal, 23S / genetics
  • Whole Genome Sequencing*
  • Young Adult

Substances

  • Anti-Bacterial Agents
  • Azithromycin
  • RNA, Ribosomal, 23S
  • Ceftriaxone
  • Cefixime